Fellowship · Boston, MA
Sponsored by Beth Israel Deaconess Medical Center
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
The New England journal of medicine · 2021 · 8,425 citations · Lindsey Baden
The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke Criteria.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023 · 656 citations · Adolf Karchmer
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
The New England journal of medicine · 2021 · 1,938 citations · Dr. Dan Barouch
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa.
Nature · 2022 · 1,410 citations · Roger Shapiro
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons.
The New England journal of medicine · 2025 · 227 citations · Kenneth Mayer
Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM).
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024 · 272 citations ·
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial.
Science (New York, N.Y.) · 2022 · 986 citations · Lindsey Baden
Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine.
The New England journal of medicine · 2021 · 885 citations · Kathryn Stephenson, Dr. Dan Barouch